Courtney Nordeck, Ph.D.

Courtney Nordeck, Ph.D.
Courtney Nordeck, Ph.D.
Assistant Research Scientist

Ph.D., Mental Health, Johns Hopkins Bloomberg School of Public Health
cnordeck@friendsresearch.org
Phone: 410-837-3977 ext. 261
Fax: 410-752-4218
Research Interests

Dr. Nordeck, a Baltimore native, is a health services researcher and epidemiologist focused on identifying strategies to improve access to effective treatment for vulnerable populations. Her research interests center around studying facilitators and barriers to treatment at individual and structural levels. Her work applies epidemiological and quantitative methodologies such as longitudinal data analysis, survival analysis, and various techniques to strengthen causal inference with observational data.

Dr. Nordeck completed her PhD in Mental Health at the Johns Hopkins Bloomberg School of Public Health, where she was a predoctoral fellow in the Drug Dependence Epidemiology T32 Training Program. Her dissertation work examined the role of homelessness in health service utilization and substance use treatment outcomes among hospitalized patients. Prior to this, she completed her Bachelor of Arts degree at New York University in Psychology.

Dr. Nordeck’s experience at FRI has spanned several projects, including serving as Lead Coordinator on a study to develop and validate a substance use screening tool for primary care and Project Managing a randomized trial examining the effectiveness of patient navigation services for hospitalized patients. She also has experience working as an external Quality Assurance Monitor for several NIDA-funded CTN studies. Currently, Dr. Nordeck is working with Dr. Jan Gryczynski on several projects related to improving treatment linkage through novel settings, such as through the Baltimore City sexual health clinics.

Selected Publications
Brenneke, S. G., Nordeck, C. D., Riehm, K. E., Schmid, I., Tormohlen, K. N., Smail, E. J., Johnson, R. M., Kalb, L. G., Stuart, E. A., & Thrul, J. (2022). Trends in cannabis use among U.S. adults amid the COVID-19 pandemic. The International Journal on Drug Policy, 100, 103517. Doi: 10.1016/j.drugpo.2021.103517.
Mitchell, S. G., Nordeck, C. D., Lertch, E., Ross, T. E., Welsh, C., Schwartz, R. P., & Gryczynski, J. (2022). Patients with substance use disorders receiving continued care in skilled nursing facilities following hospitalization. Substance Abuse, 43 (1), 848-854. Doi: 10.1080/08897077.2021.2007512.
Mun, C. J., Nordeck, C., Goodell, E. M. A., Vandrey, R., Zipunnikov, V., Dunn, K. E., Finan, P. H., & Thrul, J. (2022). Real-time monitoring of cannabis and prescription opioid co-use patterns, analgesic effectiveness, and the opioid-sparing effect of cannabis in individuals with chronic pain. The Journal of Pain, 23 (11), 1799-1810. doi: 10.1016/j.jpain.2022.06.009.
Nordeck, C., Gryczynski, J., Schwartz, R. P., Mitchell, S. G., Welsh, C., & O’Grady, K. E. (2022). Opioid agonist treatment initiation and linkage for hospitalized patients seen by a substance use disorder consultation service. Drug and Alcohol Dependence Reports, (2), 100031.
Orme, S., Zarkin, G. A., Dunlap, L. J., Nordeck, C. D., Schwartz, R. P., Mitchell, S. G., Welsh, C., O’Grady, K. E., & Gryczynski, J. (2022). Cost and cost savings of navigation services to avoid rehospitalization for a comorbid substance use disorder population. Medical Care, 60 (8), 631-635. Doi: 10.1097/mlr.0000000000001743.
Sharma A., Mitchell, S.G., Nordeck, C.D., Schwartz, R.P., Dusek, K., O’Grady, K., Gryczynski, J. (2022). Sexually Transmitted Infection (STI) testing after brief intervention for risk behaviors in school-based health centers (SBHCs) Journal of Adolescent Health, 70 (4), 577-583.
Sharma, A., Mitchell, S. G., Nordeck, C. D., Schwartz, R. P., Dusek, K., O’Grady, K. E., & Gryczynski, J. (2022). Sexually Transmitted Infection testing after brief intervention for risk behaviors in school-based health centers (SBHCs). Journal of Adolescent Health, 70(4), 577-583, doi: 10.1016/j.jadohealth.2021.11.013.
Gryczynski, J., Nordeck, C. D., Welsh, C., Schwartz, R. P., Mitchell, S. G., & O’Grady, K. E. (2021). Preventing Hospital Readmission for Patients with Comorbid Substance Use Disorder: A randomized controlled trial. Annals of Internal Medicine.
Nordeck, C.D., Riehm, K.E., Smail, E.J., Holingue, C., Kane, J.C., Johnson, R.M., Veldhuis, C.B., Kalb, L.G., Stuart, E.A., Kreuter, F., Thrul, J. (2021). Changes in drinking days among US adults during the COVID-19 pandemic. Addiction
Gryczynski, J., Nordeck, C. D., Martin, R. D., Welsh, C., Schwartz, R. P., Mitchell, S. G., & Jaffe, J. H. (2020). Leveraging health information exchange for clinical research: Extreme underreporting of hospital service utilization among patients with substance use disorders. Drug and Alcohol Dependence, 107992.
Nordeck C.D., Welsh C., Schwartz R.P., Mitchell S.G., O’Grady K.E., Dunlap L, et al. (2020). Navigation Services to Avoid Rehospitalization among Medical/Surgical Patients with Comorbid Substance Use Disorder: Rationale and Design of a Randomized Controlled Trial. Journal of Psychiatry and Brain Science.
Nordeck, C.D., Buresh, M., Krawczyk, N., Fingerhood, M., Agus, D. (2020). Adapting a low-threshold buprenorphine program for vulnerable populations during the COVID-19 pandemic. Journal of Addiction Medicine.
Nordeck, C.D., Gryczynski, J., O’Grady, K.E., Polak, K., Svikis D.S., McNeely, J., Wu, L.T., Schwartz, R.P. (2020). Comparison of timeline follow-back self-report and oral fluid testing to detect substance use in adult primary care patients. Drug and Alcohol Dependence.
Gryczynski, J., Schwartz, R. P., Fishman, M., Nordeck, C.D., Grant, J., Nidich, S., Rothenberg, S., & O’Grady, K. E. (2018). Integration of Transcendental Meditation®(TM) into alcohol use disorder (AUD) treatment. Journal of Substance Abuse Treatment, 87, 23-30.
Nordeck C.D., Welsh C., Schwartz R.P., Mitchell S.G., Cohen A., O’Grady K.E., Gryczynski J. (2018). Rehospitalization and substance use disorder (SUD) treatment entry among patients seen by a hospital SUD consultation liaison service. Drug and Alcohol Dependence.
Gryczynski J., McNeely, J., Wu, L.T., Subramaniam, G., Svikis, D., Cathers, L., Sharma, G., King, J., Jelstrom, E., Nordeck, C.D., Sharma, A., Mitchell, S., O’Grady, K.E., Schwartz, R.P. (2017). Validation of the TAPS-1: A four-item screening tool to identify unhealthy substance use in primary care. Journal of General Internal Medicine, 32(9), 990-996.
Gryczynski J., Nordeck, C.D., Mitchell, S.G., Page, K., Johnsen, L., O’Grady, K.E., Schwartz, R.P. (2017). Pilot Studies of Substance Use Disorders (SUD) Prevalence and SUD Treatment Linkage at Urban Sexually Transmitted Disease (STD) Clinics. Journal of Addiction Medicine, 11(5), 350-356.
Gryczynski, J., McNeely, J., Wu, L. T., Subramaniam, G. A., Svikis, D. S., Cathers, L. A. Sharma, G., King, J., Jelstrom E., Nordeck, C.D., Sharma A., Mitchell. A.G., O’Grady, K.E., Schwartz, R.P. (2017). Validation of the TAPS-1: a four-item screening tool to identify unhealthy substance use in primary care. Journal of general internal medicine, 32 (9), 990-996.
Schwartz, R. P., McNeely, J., Wu, L. T., Sharma, G., Wahle, A., Cushing, C., Nordeck, C.D., Sharma A., O’Grady, K.E., Gryczynski, J., Mitchell, S. G., Ali, R.L., Marsden, J., & Subramanium, G.A. (2017). Identifying substance misuse in primary care: TAPS Tool compared to the WHO ASSIST. Journal of substance abuse treatment, 76 , 69-76.
McNeely, J., Wu, L. T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck C.D., Sharma, A., O’Grady, K. E., Bouk, L.B., Cushing, C., King, J., Wahle, A., & Schwartz, R.P. (2016). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care. Annals of Internal Medicine, 165(10), 690-699.
McNeely, J., Wu, L. T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma A., O’Grady, K. E., Bouk, L.B., Cushing, C., King, J., Wahle., & Schwartz, R.P. (2016). A brief substance use screening and assessment for general medical settings: Validation of the Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool. Annals of Internal Medicine.
McNeely, J., Wu, L. T., Subramaniam, G., Sharma, G., Cathers, L. A., Svikis, D., Sleiter, L., Russell, L., Nordeck, C., Sharma A., O’Grady, K. E., Bouk, L.B., Cushing, C., King, J., Wahle., & Schwartz, R.P. (2016). Performance of the Tobacco, Alcohol, Prescription Medication, and Other Substance Use (TAPS) Tool for Substance Use Screening in Primary Care Patients. Annals of Internal Medicine.
Gryczynski, J., Nordeck, C.D., Mitchell, S. G., O’Grady, K. E., McNeely, J., Wu, L. T., & Schwartz, R. P. (2015). Reference periods in retrospective behavioral self‐report: A qualitative investigation. The American Journal on Addictions, 24(8), 744-747.
Peters, E. N., Nordeck, C.D., Zanetti, G., O’Grady, K. E., Serpelloni, G., Rimondo, C., … & Schwartz, R. P. (2015). Relationship of gambling with tobacco, alcohol, and illicit drug use among adolescents in the USA: Review of the literature 2000–2014. The American Journal on Addictions, 24(3), 206-216.